Novorapid 100Iu/ ml Penfill 3 ml is a rapid-acting human insulin analogue for the treatment of diabetes mellitus in both children (above two years of age) and adults. The active ingredient in Novorapid 100Iu/ ml Penfill 3 ml is insulin aspart. Diabetes is a medical condition where your body does not produce enough insulin to control your blood sugar level. Treatment with Novorapid 100Iu/ ml Penfill 3 ml helps to prevent complications from your diabetes.
When Novorapid 100Iu/ ml Penfill 3 ml is injected, it is extremely fast-acting and works rapidly to normalise blood sugar levels. It typically begins working after 10-20 minutes and will last for between 3 and 5 hours. Due to this short action, Novorapid 100Iu/ ml Penfill 3 ml should normally be taken in combination with intermediate-acting or long-acting insulin preparations. Novorapid 100Iu/ ml Penfill 3 ml works by ensuring rapid and consistent sugar control. Novorapid 100Iu/ ml Penfill 3 ml is a fast-acting form of insulin that helps lower blood sugar levels after food intake. Prevents the risk of having severe complications of diabetes. It stimulates the recovery of sugar in muscle and fat cells and thus suppresses sugar production in the liver.
Your doctor will advise you on how to use Novorapid 100Iu/ ml Penfill 3 ml. It should be administered at least 5-10 minutes before the meal or within 20 minutes after you start having a meal. The common side effects of Novorapid 100Iu/ ml Penfill 3 ml are hypokalaemia (low potassium), hypoglycaemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itch skin), which may occur at the injection site. Most of these side effects of Novorapid 100Iu/ ml Penfill 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Uses of Novorapid 100Iu/ ml Penfill 3 ml
Diabetes (Type 1 diabetes mellitus, Type 2 diabetes mellitus)